Ki-Ho Lee1. 1. Dept. of Biochemistry and Molecular Biology, College of Medicine, Eulji University, Daejeon 34824, Korea.
Abstract
Connexin (Cx) involves in the regulation of various physiological functions of tissue by forming a channel, a gap junction which allows direct cell-cell communication, between adjacent cells. The effect of a single subcutaneous treatment of estradiol benzoate (EB) or flutamide (Flu) at the weaning age on the expression of Cx isoforms in the adult caput epididymis was evaluated in this research. Using quantitative real-time PCR analysis, a low-dose of EB [0.015 μg/kg body weight (BW)] caused significant decreases of Cx30.3, Cx32, Cx40, Cx43, and Cx45 mRNA levels and no change of Cx26, Cx31, Cx31.1, Cx37 transcript levels. The treatment of a high-dose EB (1.5 μg/kg BW) resulted in reduced expression of Cx30.3, Cx31, Cx43, and Cx45 but increased expression of Cx37 and Cx40. Expression of all Cx isoforms examined, except Cx31, was significantly increased by the treatment of a low-dose Flu (500 μg/kg BW). However, the treatment of a high-dose Flu (5 mg/kg BW) led significant expressional suppression of Cx30.3, Cx31, Cx31.1, Cx32, Cx40, Cx43, and Cx45 but an increase of Cx37 transcript level. With the comparison of previous findings, the expression of Cx isoforms in the adult epididymis after the exposure to EB or Flu is likely differentially regulated in regional-specific and/or exposed postnatal age-specific manner.
Connexin (Cx) involves in the regulation of various physiological functions of tissue by forming a channel, a gap junction which allows direct cell-cell communication, between adjacent cells. The effect of a single subcutaneous treatment of estradiol benzoate (EB) or flutamide (Flu) at the weaning age on the expression of Cx isoforms in the adult caput epididymis was evaluated in this research. Using quantitative real-time PCR analysis, a low-dose of EB [0.015 μg/kg body weight (BW)] caused significant decreases of Cx30.3, Cx32, Cx40, Cx43, and Cx45 mRNA levels and no change of Cx26, Cx31, Cx31.1, Cx37 transcript levels. The treatment of a high-dose EB (1.5 μg/kg BW) resulted in reduced expression of Cx30.3, Cx31, Cx43, and Cx45 but increased expression of Cx37 and Cx40. Expression of all Cx isoforms examined, except Cx31, was significantly increased by the treatment of a low-dose Flu (500 μg/kg BW). However, the treatment of a high-dose Flu (5 mg/kg BW) led significant expressional suppression of Cx30.3, Cx31, Cx31.1, Cx32, Cx40, Cx43, and Cx45 but an increase of Cx37 transcript level. With the comparison of previous findings, the expression of Cx isoforms in the adult epididymis after the exposure to EB or Flu is likely differentially regulated in regional-specific and/or exposed postnatal age-specific manner.
Entities:
Keywords:
Caput epididymis; Connexin; Estradiol benzoate; Flutamide; Quantitative real-time PCR
The epididymis of the male reproductive tract is the place where sperm produced from
the testis becomes mature and acquires fertilizing capacity. The epididymis has a
layer of epithelial lumen surrounded by smooth layers, and the epididymal epithelium
is composed of several cell types, for example principal, halo, clear, basal, and
apical cells, possessing distinctive functions (Robaire & Hermo, 1988) Based on histochemical and functional
aspects, the epididymis is divided into four parts, initial segment, caput
epididymis, corpus epididymis, and caudal epididymis (Robaire & Hermo, 1988). Of these epididymal regions, the
caput epididymis has some features distinct from other parts of the epididymis.
These include different composition of epithelial cell types (Robaire & Hermo, 1988), thickness of the epithelium (Robaire & Hermo, 1988), and different
expressional levels of certain molecules, such as androgen receptor and 5α-reductase
(Robaire et al., 2006). Thus, it is
generally acknowledged that the caput epididymis gives an influence on sperm
maturation in ways different from other epididymal segments.In multicellular tissue, Cellular communication between adjacent cells is mostly
directed by one or more types of junctional complexes, such as tight junction,
adherens junction, and gap junction (Lawrence et al.,
1978). However, gap junctional complex only allows the functional
accordance of neighboring cells by direct exchange of small molecules, including
signaling molecules, ions, and some metabolites (Valiunas et al., 2005). The gap junction is composed of six connexin
(Cx) subunits, forming a channel between contiguous cells (Lawrence et al., 1978). To date, 21 Cx isoforms
have been found in vertebrates, and all cells virtually possess one type of
Cx isoforms at least (Goodenough
& Paul, 2009). Many researches have demonstrated that certain
Cx isoforms are frequently found in most of tissues and others
are expressed in restricted cell types (Goodenough
& Paul, 2009; Meşe et al.,
2007). Other studies have also showed co-expression of more than two
types of Cx isoforms and differential expression of several
Cx isoforms during the development in a cell (Goodenough & Paul, 2009; Meşe et al., 2007). The existence of
Cx isoforms in the male reproductive tract has been extensively
examined. The expression of Cx isoforms in the epididymis has been
determined by our previous researches, and the expression of a total of 9
Cx isoforms, including Cx26,
Cx30.3, Cx31, Cx31.1,
Cx32, Cx37, Cx40,
Cx43, and Cx45, have been identified in the
epididymis (Han & Lee, 2013; Lee, 2013; Seo
et al., 2010). Moreover, these Cx isoforms in the
epididymis have been differentially expressed according to the segment and/or age
during postnatal development (Seo et al.,
2010; Han & Lee, 2013; Lee, 2013). The localization of
Cx43 between basal and principal cells in the rat caput
epididymis has been detected by Cyr et al
(1996). However, addition information for the localization of other
Cx isoforms in the epididymis is limited to date.The expression of Cx isoforms in the epididymis is regulated by
various intrinsic and/or extrinsic factors. The expression of Cx43
in the ratcaudal epididymis is controlled by testis-originated factor(s) because
the removal of testis results in the disappearance of immunoreactivity of
Cx43 (Cyr et al., 1996).
In addition, the expressional stimulation of Cx43 in humanepididymis by epidermal growth factor has been reported (Dubé et al., 2012). Propylthiouracil-induced hypothyroidism at
the neonatal age induces a significant decrease of Cx43 expression
in the entire epididymal region, except caudal epididymis, indicating a possible
role of thyroid hormone on expression of Cx43 in the epididymis
(St-Pierre et al., 2003). It is
well-documented that the function of epididymis is largely regulated by androgen, as
well as estrogen (Robaire & Hamzeh, 2011;
Schulster et al., 2016). Thus, the
possibility of expressional regulation of Cx isoforms in the
epididymis by androgen and/or estrogen-related compounds has been suggested. Indeed,
the exposure to flutamide (Flu), an anti-androgenic substance, at the late
gestational age or early postnatal age causes a decrease of Cx43
expression in the cauda epididymis (Lydka et al.,
2011). In addition, our previous researches have demonstrated the effects
of flutamide and estradiol benzoate (EB), an estrogenic compound, treatments at the
early neonatal age on expression of Cx isoforms within different
epididymal segments (Lee, 2015, 2016a, 2017). Moreover, the exposure of these substances at different postnatal
age results in differential expression of Cx isoforms within corpus
or caudal epididymal region (Lee, 2015, 2016a, 2016b; Lee & Lee, 2015).
Recently, after the exposure to Flu or EB at the early neonatal age, expressional
changes of Cx isoforms in the adult caput epididymis have been
evaluated (Lee, 2017). But, the influence of
Flu or EB treatment at different age on expression of Cx isoforms
in the caput epididymis has not been studied. Thus, the aim of the present research
was to evaluate the changes of expression of Cx isoforms in the
adult caput epididymis treated with Flu or EB at the weaning.
MATERIALS AND METHODS
1. Experimental animals and design
Pregnant Sprague Dawley female rats were purchased from Samtako (OSan, Korea) and
were separated in individual until the delivery and weaning of pups. The
pregnant rats were randomly assigned into one of five experimental groups,
including control group treated with peanut oil (n=6), a low-dose EB [EB-L,
0.015 μg of EB/kg body weight (BW), n=6] treated group, a high-dose EB (EB-H,
1.5 μg of EB/kg BW, n=6) treated group, a low-dose Flu (Flu-L, 500 μg of Flu/kg
BW, n=6) treated group, and a high-dose Flu (Flu-H, 5 mg of Flu/kg BW, n=6)
treated group. The animal was allowed to freely access food and drinking water
during the entire experimental period.To prepare EB or Flu solution to be injected, the powder forms of EB and Flu were
obtained from Tokyo Chemical Industry Co. (Tokyo, Japan). The adequate amount of
EB or Flu was completely dissolved in 100% EtOH, and the concentrated solution
was then diluted in peanut oil to get working solution of EB or Flu. At the
weaning, the animal was weighted and was subcutaneously administrated with a
proper amount of EB or Flu working solution. The volume of injected EB or Flu
solution or peanut oil did not exceed 0.05 mL. The current work was conducted in
accordance with the guide for the care and use of laboratory animals of National
Research Council in S. Korea.
2. Tissue preparation and isolation of total RNA from the tissue
The experimental animal at 4 months of age was euthanized by CO2
stunning, and an incision on lower abdomen was made to take out the male
reproductive tract. In the cold PBS buffer, the epididymis was separated from
the rest and was additionally divided into individual epididymal parts. The
caput epididymis was transferred to and washed in new cold PBS buffer and was
rapidly placed in liquid nitrogen. Frozen tissue was stored in –80℃ and was used
for total RNA isolation.The extraction of total RNA was began with the homogenization of tissue in the
RNA extraction solution (iNtRON Biotech, Sungnam, Korea). The precipitation of
total RNA was carried out with the addition of isopropanol. After the washing in
70% DEPC-EtOH, total RNA pellet was air-dried and then resuspended in DEPC-
dH2O. The amount and purity of total RNA isolated were calculated
with NanoDrop Lite spectrophotomer (Thermo Scientific, Wilmington, DE), and the
qualitative condition of total RNA was checked by 1.2% agarose gel
electrophoresis.
3. Preparation of complementary DNA from total RNA and procedure of
quantitative real-time PCR
A mixture of 1 μg of total RNA, oligo-dT primer, ImProm- IITM reverse
transcription system (Promega, Madison, WI), and dH2O in a total
volume of 20 μL was prepared to construct the first-stranded complementary DNA
(cDNA). The mixture was placed in a sequential step of 25℃ for 5 min, 42℃ for 90
min, and 70℃ for 15 min to carry out the reverse transcription reaction. The
generated cDNA was utilized as a template DNA for quantitative real- time PCR
analysis.A mixture of 1 μL of cDNA, 10 pmol of each primer, 10 μL PCR master mixture
(Finnzymes, Espoo, Finland), and DNase-free dH2O in a final volume of
20 μL was made for quantitative real-time PCR analysis of each
Cx isoform. Table 1
shows detailed information of oligonucleotide primers and condition used for
real-time PCR analysis. The PCR was undertaken in a thermocycler (Bio-Rad
Laboratories, Hercules, CA) with a series of steps as followings; a
pre-denaturation step at 95℃ for 30 sec, 35 cycles of denaturation at 95℃ for 30
sec, annealing at Tm for 30 sec, and extension at 72℃ for 30 sec, and
a final extension step at 72℃ for 5 min. Cyclophilin A (Ppia)
was used for an internal control of quantitative real-time PCR.
Table 1
Sequence informationof primers used for real-time PCR
analysis
Cx :connexin; Ppia : peptidylprolyl
isomerase A (cyclophilin A).
Cx :connexin; Ppia : peptidylprolyl
isomerase A (cyclophilin A).
4. Analysis and presentation of data
The RT reactions and PCRs were independently quadruplicated to get a mean and a
standard error of an experimental group. The experimental results were reported
in the relative ratios of expression between Ppia and
Cx isoforms. Statistical significance of
Cx expressional level among control and two experimental
groups of EB or Flu treatment was determined by one-way ANOVA, followed by
Duncan’s test. If P < 0.05, it was considered that there was
a statistical difference between two groups.
RESULTS
1. Changes of Cx26 and Cx30.3 expression in
the caput epididymis of rat exposed to EB or Flu at the weaning
As shown in Fig. 1A, there was no
significant change of Cx26 transcript level with EB treatment
at both low and high doses. However, a significant increase of
Cx26 expression was detected with a low-dose treatment of
Flu (Fig. 1A). The treatment of Flu at a
high-dose didn’t give a significant influence on the level of
Cx26 transcript.
Fig. 1
Expression levels of Cx26 and
Cx30.3 in the adult caput epididymis exposed to
estradiol benzoate (EB) or flutamide (Flu) at the weaning.
A single subcutaneous shot of a low-dose EB (0.015 μg/kg BW, EB-L), a
high-dose EB (1.5 μg/kg BW, EB-H), a low-dose Flu (500 μg /kg BW,
Flu-L), a high-dose Flu (50 mg/kg body weight, Flu-H), or peanut oil for
control (C) was injected at the weaning. The different letters indicate
statistical differences among control and two experimental groups of EB
or Flu treatment on Cx26 transcript level (A) or
Cx30.3 transcript level (B).
Expression of Cx30.3 in the adult caput epididymis was
significantly decreased by a low-dose EB treatment at the weaning (Fig. 1B). Even though a high-dose EB
treatment also caused a decrease of Cx30.3 transcript level,
there was no difference on Cx30.3 transcript level between a
low-dose and a high-dose EB treatment (Fig.
1B). A significant induction of Cx30.3 expression
was observed with a low-dose Flu treatment, but a high-dose Flu treatment at the
weaning resulted in a decrease of Cx30.3 mRNA level in the
adult caput epididymis (Fig. 1B).
Expression levels of Cx26 and
Cx30.3 in the adult caput epididymis exposed to
estradiol benzoate (EB) or flutamide (Flu) at the weaning.
A single subcutaneous shot of a low-dose EB (0.015 μg/kg BW, EB-L), a
high-dose EB (1.5 μg/kg BW, EB-H), a low-dose Flu (500 μg /kg BW,
Flu-L), a high-dose Flu (50 mg/kg body weight, Flu-H), or peanut oil for
control (C) was injected at the weaning. The different letters indicate
statistical differences among control and two experimental groups of EB
or Flu treatment on Cx26 transcript level (A) or
Cx30.3 transcript level (B).
2. Changes of Cx31 and Cx31.1 expression in
the caput epididymis of rat exposed to EB or Flu at the weaning
The level of Cx31 transcript in the adult caput epididymis was
not changed by the administration of a low-dose EB at the weaning (Fig. 2A). But, a significant reduction of
Cx31 transcript level was observed with a high-dose EB
treatment (Fig. 2A). Similarly, the
treatment of a low-dose Flu at the weaning didn’t affect the expression of
Cx31 in the adult caput epididymis, while the expression of
Cx31 was greatly decreased by the treatment of a high-dose
Flu (Fig. 2A).
Fig. 2
Expression levels of Cx31 and
Cx31.1 in the adult caput epididymis exposed to
estradiol benzoate (EB) or flutamide (Flu) at the weaning.
A single subcutaneous shot of a low-dose EB (0.015 μg/kg BW, EB-L), a
high-dose EB (1.5 μg/kg BW, EB-H), a low-dose Flu (500 μg /kg BW,
Flu-L), a high-dose Flu (50 mg/kg body weight, Flu-H), or peanut oil for
control (C) was injected at the weaning. The different letters indicate
statistical differences among control and two experimental groups of EB
or Flu treatment on Cx31 transcript level (A) or
Cx31.1 transcript level (B).
Neither a low-dose EB treatment nor a high-dose EB treatment gave any significant
effect on the expressional change of Cx31.1 (Fig. 2B). The administration of a low-dose
Flu at the weaning caused a clear increase of Cx31.1 transcript
level in the adult caput epididymis (Fig.
2B). But, a significant decrease of Cx31.1 mRNA
abundance in the adult caput epididymis was detected in the high-dose Flu
treated-group (Fig. 2B).
Expression levels of Cx31 and
Cx31.1 in the adult caput epididymis exposed to
estradiol benzoate (EB) or flutamide (Flu) at the weaning.
A single subcutaneous shot of a low-dose EB (0.015 μg/kg BW, EB-L), a
high-dose EB (1.5 μg/kg BW, EB-H), a low-dose Flu (500 μg /kg BW,
Flu-L), a high-dose Flu (50 mg/kg body weight, Flu-H), or peanut oil for
control (C) was injected at the weaning. The different letters indicate
statistical differences among control and two experimental groups of EB
or Flu treatment on Cx31 transcript level (A) or
Cx31.1 transcript level (B).
3. Changes of Cx32 and Cx37 expression in
the caput epididymis of rat exposed to EB or Flu at the weaning
A significantly lower level of Cx32 in a low-dose EB
treated-group at the weaning than that in the control was detected in the adult
caput epididymis, even though there was no significant change of
Cx32 transcript level in a high-dose EB treated-group
(Fig. 3A). The level of
Cx32 transcript was significantly increased by a low-dose
Flu treatment, but the treatment of a high-dose Flu led to a significant
decrease of Cx32 transcript level (Fig. 3A).
Fig. 3
Expression levels of Cx32 and Cx37
in the adult caput epididymis exposed to estradiol benzoate (EB) or
flutamide (Flu) at the weaning.
A single subcutaneous shot of a low-dose EB (0.015 μg/kg BW, EB-L), a
high-dose EB (1.5 μg/kg BW, EB-H), a low-dose Flu (500 μg /kg BW,
Flu-L), a high-dose Flu (50 mg/kg body weight, Flu-H), or peanut oil for
control (C) was injected at the weaning. The different letters indicate
statistical differences among control and two experimental groups of EB
or Flu treatment on Cx32 transcript level (A) or
Cx37 transcript level (B).
Expression of Cx37 in the adult caput epididymis was not changed
by a low-dose EB treatment at the weaning (Fig.
3B). However, the treatment of a high-dose EB at the weaning resulted
in a significant induction of Cx37 expression (Fig. 3B). The treatment of Flu at a low-dose
caused a significant increase of Cx37 transcript level (Fig. 3B). The expressional level of
Cx37 in a high-dose Flu treated-group was significantly
higher than that in control but lower than that in a low-dose Flu treated-group
(Fig. 3B).
Expression levels of Cx32 and Cx37
in the adult caput epididymis exposed to estradiol benzoate (EB) or
flutamide (Flu) at the weaning.
A single subcutaneous shot of a low-dose EB (0.015 μg/kg BW, EB-L), a
high-dose EB (1.5 μg/kg BW, EB-H), a low-dose Flu (500 μg /kg BW,
Flu-L), a high-dose Flu (50 mg/kg body weight, Flu-H), or peanut oil for
control (C) was injected at the weaning. The different letters indicate
statistical differences among control and two experimental groups of EB
or Flu treatment on Cx32 transcript level (A) or
Cx37 transcript level (B).
4. Changes of Cx40, Cx43, and
Cx45 expression in the caput epididymis of rat exposed to
EB or Flu at the weaning
The transcript level of Cx40 in the adult caput epididymis was
significantly decreased by a low-dose EB treatment at the weaning (Fig. 4A). However, the exposure to a
high-dose EB at the weaning resulted in a significant increase of
Cx40 mRNA level (Fig.
4A). An increase of Cx40 transcript level in the
adult caput epididymis was detected by a low-dose Flu treatment at the weaning,
while the treatment of a high-dose Flu caused a significant decrease of
Cx40 mRNA amount (Fig.
4A).
Fig. 4
Expression levels of Cx40, Cx43,
and Cx45 in the adult caput epididymis exposed to
estradiol benzoate (EB) or flutamide (Flu) at the weaning.
A single subcutaneous shot of a low-dose EB (0.015 μg/kg BW, EB-L), a
high-dose EB (1.5 μg/kg BW, EB-H), a low-dose Flu (500 μg /kg BW,
Flu-L), a high-dose Flu (50 mg/kg body weight, Flu-H), or peanut oil for
control (C) was injected at the weaning. The different letters indicate
statistical differences among control and two experimental groups of EB
or Flu treatment on Cx40 transcript level (A),
Cx43 transcript level (B), or Cx45
transcript level (C).
The expression of Cx43 in the adult caput epididymis was
significantly decreased by both low- and high-dose EB treatments at the weaning
(Fig. 4B). But, the level of
Cx43 transcript was significantly lower in a low-dose EB
treated-group than a high-dose EB treated-group (Fig. 4B). A great increase of
Cx43 mRNA level in the adult caput epididymis was observed
with a low-dose Flu treatment at the weaning (Fig.
4B). In the other hand, a high-dose Flu treatment caused a decrease
of Cx43 transcript level (Fig.
4B).The treatments of both low- and high-dose EB at the weaning resulted in
significant reduction of Cx45 trans- cript level in the adult
caput epididymis (Fig. 4C). An increase of
Cx45 expression in the adult caput epididymis was found in
a low-dose Flu treated-group, but the treatment of a high-dose Flu at the
weaning resulted in a significant decrease of Cx45 transcript
level in the adult caput epididymis (Fig.
4C).
Expression levels of Cx40, Cx43,
and Cx45 in the adult caput epididymis exposed to
estradiol benzoate (EB) or flutamide (Flu) at the weaning.
A single subcutaneous shot of a low-dose EB (0.015 μg/kg BW, EB-L), a
high-dose EB (1.5 μg/kg BW, EB-H), a low-dose Flu (500 μg /kg BW,
Flu-L), a high-dose Flu (50 mg/kg body weight, Flu-H), or peanut oil for
control (C) was injected at the weaning. The different letters indicate
statistical differences among control and two experimental groups of EB
or Flu treatment on Cx40 transcript level (A),
Cx43 transcript level (B), or Cx45
transcript level (C).
DISCUSSION
The expression of Cx isoforms in the adult rat caput epididymis
after the exposure to Flu or EB at the weaning has been examined in the present
study. Even though expressional changes of Cx isoforms by the EB
treatments at two doses are somewhat not uniformed, in general, a low-dose Flu
treatment causes expressional increases of most Cx isoforms and a
high-dose Flu treatment results in expressional decreases of most
Cx isoforms in the caput epididymis.Aberrant expression of Cx isoforms in the adult corpus and caudal
epididymis after Flu or EB treatment at the weaning has been reported from our
previous researches (Lee & Lee, 2015;
Lee 2016b). Each Cx
isoform has shown different responses to Flu or EB treatment at the weaning age
according to the epididymal region and/or dose of treatment. For example, expression
of Cx26 in the adult corpus epididymis is significantly increased
by a high-dose EB treatment but significantly decreased by a high-dose Flu treatment
(Lee & Lee, 2015). With the same
treatment, in the adult caudal epididymis, expression of Cx26 is
not changed by EB treatment but significantly increased by Flu treatment at two
doses (Lee, 2016b). Different expressional
response of Cx43 has been observed in corpus and caudal epididymis
after the same Flu or EB treatment. That is, expression of Cx43 in
the adult corpus epididymis is significantly increased by a low-dose EB treatment
but decreased by a high-dose EB and two-doses Flu treatments (Lee & Lee, 2015). Interestingly, expression of
Cx43 in the adult caudal epididymis is significantly increased
by EB or Flu treatment at the weaning age (Lee,
2016b). In the present study, the EB treatment has not affected the
expression of Cx26, but a low-dose Flu treatment results in an
increased of Cx26 expression. Expression of Cx43
is significantly decreased by EB treatment, but a low-dose Flu treatment results in
a significantly increase of Cx43 expression, while a significantly
reduction of Cx43 expression is detected by a high-Flu treatment.
Together, these observations suggest that expression of each Cx
isoforms in the epididymis is differentially regulated during postnatal development
in a segment-specific manner.Abnormal expression of Cx isoforms in the adult epididymis by EB or
Flu treatment are likely influenced by the time of exposure during the early
postnatal development. Our earlier researches have showed differential expressional
patterns of each Cx isoforms within the adult corpus or caudal
epididymis after the EB or Flu treatment at 1 week or 3 weeks of postnatal age
(Lee & Lee 2015; Lee 2015, 2016a, 2016b). The comparison of
the findings of current research and a previous study (Lee 2017) in the caput epididymis also supports the view that
expression of Cx isoforms in the adult epididymis could be
differentially appeared according to the time of contract to exogenous substance.
Indeed, Ma et al (2017) have demonstrated
differential gene expression in the adult rat spleen after the exposure to fluoride
at different postnatal age. In addition, the exposure to N-methyl-N-nitrosourea at
different age during pre- and post-pubertal period results in differential
expression of COX2 in granule cells, affecting pattern of normal neurogenesis in rat
hippocampus (Watanabe et al., 2017).
Therefore, it is also acceptable that EB or Flu treatment at different postnatal age
could result in differential expression of Cx isoforms.A couple of explanations about what causes such differential expression of
Cx isoforms in the adult epididymis after EB or Flu treatment
at different postnatal age are suggested. One explanation is related with
differentiation of epididymal epithelial cells during postnatal period. The
undifferentiated epithelial cells in the epididymis at the birth undergo a large
histological change during the early infancy, and the first differentiated cell,
halo cell, appears at the infancy (Arrotéia et al.,
2012). After the appearance of halo cell, until the puberty, the
undifferentiated epididymal epithelial cells become first differentiated into
columnar or non-columnar cells (Arrotéia et al.,
2012). Then the columnar cells develop into principal and basal cells and
noncolumnar cells are differentiated into apical, narrow, and clear cells over
postnatal time (Arrotéia et al., 2012). Thus,
if EB or Flu treatment is carried out at different postnatal age, it is considered
that the treatment could influence on the differentiation of epididymal epithelial
cell and thereby result in disruption of proper development of epithelial cells in
the adult epididymis. This phenomenon could end up with aberrant expression of
cellular molecules, including Cx isoforms, and consequently
functional abnormality of the epididymis. The other possibility to describe
differential effects of EB or Flu treatment at different postnatal age on expression
of Cx isoforms in the epididymis is due to differential expression
of androgen receptor (AR) and estrogen receptor (ER) in the epididymis during
postnatal period. The Flu is a pure anti-androgen acting with AR to regulate
expression of androgen-responsive genes (Tan et al.,
2015). The expression of AR in the epididymis is elevated during
postnatal period, especially with a surgical increase of AR expression for the early
postpartum period (You & Sar, 1998). The
EB is an estrogen-agonistic compound acting through ER to regulate gene expression
(Serova et al., 2010). The expression of
ERα in the epididymis during postnatal development is under the regional- and
age-specific patterns, and the exposure to diethylstilbestrol leads into disrupted
expression of ERα in the epididymis (Atanassova et
al., 2001). These earlier observations would support that the treatment
of EB and/or Flu at different postnatal age could manipulate expression of AR or ER
in the adult epididymis and thus cause abnormal expression of androgen- and/or
estrogen-responsive genes, such as likely Cx isoforms. Detailed
molecular examination on expressional regulation of Cx isoforms in
the epididymis by androgen and estrogen should be conducted in future.In conclusion, the present research exhibits that expression of Cx
isoforms in the adult caput epididymis is modulated by the treatment of EB or Flu at
the weaning age. In addition, the data from the current study also show that the EB
or Flu treatment at different postnatal age results in differential expression of a
given Cx isoform in the adult caput epididymis. However, it still
remains to be answered if the abnormal expression of Cx isoforms in
the epididymis by EB or Flu treatment is related with a disruption of epididymal
function.